Market intelligence company Millennium Research Group, reckons the U.S. Transcatheter Embolisation and Occlusion device market will grow at an average annual rate of just over nine percent through 2016, driven by an aging population and a trend away from traditional surgical procedures and toward minimally invasive procedures, with particular growth in aneurysm treatment.
Neurovascular
Brazilian Approval For Covidien’s Solitaire FR Revascularization Device
There’s no stopping Covidien’ s neurovascular clot retrieval device, which the company has announced can now add Brazil to Europe and USA as territories wher eit is approved for sale.
FDA Clears Covidien’s Solitaire™ FR Revascularisation Device
With a certain inevitability following rave reviews in its pivotal clinical study, Covidien’s revascularisation device for removing clots from occluded vessels in stroke patients has now gained FDA 510(k) clearance.